SH
SOSV's HAX
Newark, New Jersey, United StatesFounded 2011
SOSV's HAX invests in pre-seed and seed-stage "hard tech" startups that tackle complex problems in human and planetary health, spanning areas like industrial automation, climate tech, and advanced manufacturing. Their strategy involves hands-on support, providing capital, extensive engineering resources, and a residency program to help founders rapidly prototype, de-risk technology, and achieve market traction.
Portfolio
2
Fund Size
$1.5B
Top Stage
Seed
Last 12 Mo
0
Stage Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Flow Neuroscience | Series A | $7.9M | Aug 2021 |
| Allozymes | Seed | $5M | Jul 2021 |
Top Co-Investors
Last updated: 3 March 2026